fdalawblog.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.fdalawblog.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | FDA Law Update Blog | Sheppard |
| Description | FDA Law Update Blog provides up-to-date information on current issues affecting FDA-regulated companies & |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.207.123 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
fdalawblog.com Valuation
|
US$1,341,519
Last updated: 2023-05-10 17:34:41
fdalawblog.com has Semrush global rank of 7,889,794. fdalawblog.com has an estimated worth of US$ 1,341,519, based on its estimated Ads revenue. fdalawblog.com receives approximately 154,791 unique visitors each day. Its web server is located in United States, with IP address 172.67.207.123. According to SiteAdvisor, fdalawblog.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,341,519 |
| Daily Ads Revenue | US$1,239 |
| Monthly Ads Revenue | US$37,150 |
| Yearly Ads Revenue | US$445,797 |
| Daily Unique Visitors | 10,320 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| fdalawblog.com. | A | 300 | IP: 172.67.207.123 |
| fdalawblog.com. | A | 300 | IP: 104.21.42.181 |
| fdalawblog.com. | AAAA | 300 | IPV6: 2606:4700:3035::ac43:cf7b |
| fdalawblog.com. | AAAA | 300 | IPV6: 2606:4700:3030::6815:2ab5 |
| fdalawblog.com. | NS | 86400 | NS Record: betty.ns.cloudflare.com. |
| fdalawblog.com. | NS | 86400 | NS Record: drew.ns.cloudflare.com. |
| fdalawblog.com. | MX | 300 | MX Record: 0 dc-2c68b1a5a72f.fdalawblog.com. |
HtmlToTextCheckTime:2023-05-10 17:34:41
| Menu Current Page: Home Practice Contact Search… Search FDA Law Update Current Issues Affecting FDA-Regulated Companies Withdrawal of Drug Approval Highlights Risk of Accelerated Approval Pathway By Dominick DiSabatino & Audrey Crowell on April 26, 2023 Posted in FDA , Prescription and OTC Drugs On April 5, 2023, the U.S. Food and Drug Administration (“FDA”) announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection (“Makena”) – a drug that was approved in 2011 to reduce the risk of preterm birth in certain pregnant women. [1] The final decision followed a hearing and appeal process that took nearly three years, and cited the failure of post-approval studies to prove the drug’s effectiveness as the reason for the withdrawal. [2] … Continue Reading Withdrawal of Drug Approval Highlights Risk of Accelerated Approval Pathway Access to Abortion Pill in Limbo: Navigating the Intricacies of FDA Approval as well as Conflicting Federal Court Rulings By |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 03 Nov 2021 04:13:42 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Wed, 03 Nov 2021 05:13:42 GMT
Location: https://fdalawblog.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=VmW0R3VhzxyrgJFA%2FnZkYQWKKY9hKM324rUy1aijNZ2sEpH9uBb6NKJ3VIereR%2B1bj0nG5M%2BIH1tX%2Fq6jem6ePPObGO%2B889SEBw%2BXhly3SbPQdNGDLy7KoL6xTZxp3C%2BUQ%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a82c581cedb6308-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 301
date: Wed, 03 Nov 2021 04:13:42 GMT
cache-control: max-age=3600
expires: Wed, 03 Nov 2021 05:13:42 GMT
location: https://www.fdalawblog.com/
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=EzZC1ZALR3lcm%2FNyHNcpzWRCAnSqbu6jQgUL9eFVHMM8Bs0J73qH3IV10ngou49QFH2s%2BzKWj9ltLTpQJ2gr7XLJW6MZuflL1rsXlNOYW1hrJfl9H47ngjEGpiSXzD6K1g%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a82c5823ba72968-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Wed, 03 Nov 2021 04:13:42 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
vary: Accept-Encoding,Cookie
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
x-frame-options: sameorigin
x-xss-protection: 1; mode=block
referrer-policy: same-origin
content-security-policy: default-src https: data: wss: 'unsafe-inline' 'unsafe-eval'; object-src 'none';
link:
|
fdalawblog.com Whois Information
Domain Name: FDALAWBLOG.COM Registry Domain ID: 353809743_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-12T21:07:46Z Creation Date: 2006-02-21T20:10:12Z Registry Expiry Date: 2022-02-21T20:10:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: BETTY.NS.CLOUDFLARE.COM Name Server: DREW.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-29T09:25:13Z <<< |